Abstracts Archive - Page 1817 of 2607 - ACR Meeting Abstracts

Abstract Number: 2448 • 2015 ACR/ARHP Annual Meeting
Flare Definitions for Juvenile Idiopathic Arthritis (JIA) Based on ACR Core Set Variables and Patient Reported Outcomes: Results from the Research in Arthritis in Canadian Children-Emphasizing Outcomes Prospective Cohort
Vinay Shivamurthy¹, Deborah M. Levy², Gilles Boire³, Karen N Watanabe Duffy⁴, Elizabeth Stringer⁵, Rosie Scuccimarri⁶, Rae S.M. Yeung⁷, Adam M. Huber⁸, Kiem Oen⁹, Natalie Shiff¹⁰, Lori B. Tucker¹¹, Roberta Berard¹², Kimberly Morishita¹³, Ciarán M. Duffy¹⁴ and Jaime Guzman¹⁵, ¹Pediatrics/Rheumatology, British Columbia Children's Hospital, Vancouver, BC, Canada, ²Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ³Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, ⁴Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, ⁵Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, ⁶Pediatrics, McGill University, Montréal, QC, Canada, ⁷Pediatrics, Immunology and Medical Science, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, ⁸Pediatric rheumatology, IWK Health Centre, Halifax, NS, Canada, ⁹University of Manitoba, Winnipeg, MB, Canada, ¹⁰Pediatric Rheumatology, University of Saskatchewan, Saskatoon, SK, Canada, ¹¹Rheumatology, BC Children's Hospital, Vancouver, BC, Canada, ¹²Children's Hospital of Western Ontario, London, ON, Canada, ¹³Pediatric Rheumatology, BC's Children's Hospital, Vancouver, BC, Canada, ¹⁴Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, ¹⁵Rheumatology, Division of Rheumatology, BC Children's Hospital, Vancouver, BC, Canada
Background/Purpose: A valid flare definition is needed in clinical practice to identify a clinically relevant worsening which will guide us make treatment decisions. While the…
Abstract Number: 2449 • 2015 ACR/ARHP Annual Meeting
Does Antinuclear Antibodies Predict Remission in JIA ?
Mia Glerup¹, Troels Herlin² and Marinka Twilt³, ¹Pediatrics, Aarhus University Hospital, Skejby, Aarhus, Denmark, ²Department of Pediatrics, Århus University Hospital Skejby, Århus, Denmark, ³Rheumatology, Alberta Children's Hospital, Calgary, AB, Canada
Background/Purpose: In the recent years the classification of Juvenile Idiopathic Arthritis (JIA) according to the ILAR criteria has been questioned as some categories still include…
Abstract Number: 2450 • 2015 ACR/ARHP Annual Meeting
Examination of the Clinical Significance of 14-3-3 Eta in Juvenile Idiopathic Arthritis
Lance Feller¹, Austin M. Dalrymple², Paul Tuttle IV³, Reema H. Syed³, Peri Pepmueller¹ and Terry Moore⁴, ¹Rheumatology, Saint Louis University, St. Louis, MO, ²Pediatric Rheumatology, St. Louis University, St. Louis, MO, ³IM-Rheumatology, Saint Louis University, St. Louis, MO, ⁴Division of Rheumatology and Pediatric Rheumatology, Saint Louis University School of Medicine, St Louis, MO
Background/Purpose: 14-3-3 proteins are chaperonins found in all eukaryotic cells. There are multiple isoforms which are thought to be involved in intracellular signaling and transcription…
Abstract Number: 2451 • 2015 ACR/ARHP Annual Meeting
Scoring Medication Requirements and Side-Effects in Juvenile Idiopathic Arthritis: Perspectives of Patients, Parents and Clinicians
Lori B. Tucker¹, Natalie Shiff², Susanne Benseler³, Roberta Berard⁴, Roman Jurencak⁵, Thomas Loughin⁶, Jaime Guzman⁷ and Andrew Henrey⁶, ¹Rheumatology, BC Children's Hospital, Vancouver, BC, Canada, ²Pediatric Rheumatology, University of Saskatchewan, Saskatoon, SK, Canada, ³Pediatrics, University of Calgary, Toronto, ON, Canada, ⁴Children's Hospital of Western Ontario, London, ON, Canada, ⁵University of Ottawa, Ottawa, ON, Canada, ⁶Statistics and Actuarial Science, Simon Fraser University, Burnaby, BC, Canada, ⁷Rheumatology, Division of Rheumatology, BC Children's Hospital, Vancouver, BC, Canada
Background/Purpose: Medication requirements (MedReq) and medication side effects (MedSE) were found to be top priorities by patients, parents and clinicians in describing the course of…
Abstract Number: 2452 • 2015 ACR/ARHP Annual Meeting
Clinical and Functional Outcomes in Patients with Polyarticular Juvenile Idiopathic Arthritis Following Treatment with Adalimumab
Daniel J. Kingsbury¹, Pierre Quartier², G Horneff³, Kirsten Minden⁴, Mary Toth⁵, Nupun A. Varothai⁶, Anabela Cardoso⁷ and Jasmina Kalabic⁶, ¹Randall Children's Hospital at Legacy Emanuel, Portland, OR, ²Hopital Necker-Enfants Malades, Paris, France, ³Asklepios Klinik Sankt Augustin, Sankt Augustin, Germany, ⁴Kinderklinik der Charite, Otto-Heubner Centrum, Berlin, Germany, ⁵Akron Children's Hospital, Akron, OH, ⁶AbbVie, North Chicago, IL, ⁷AbbVie, Amadora, Portugal
Background/Purpose: The Juvenile Arthritis Disease Activity Score (JADAS) is increasingly accepted for defining a treat-to-target strategy in patients (pts) with juvenile idiopathic arthritis (JIA)1 The…
Abstract Number: 2453 • 2015 ACR/ARHP Annual Meeting
Evidence-Based Decision Support for Pediatric Rheumatology Reduces Diagnostic Errors, with the Potential to Reduce Capacity Shortage
Balu Athreya¹, Mary Beth Son², Jonathan S. Hausmann³, Elizabeth Ang⁴, David Zurakowski⁵, Michael Segal⁶ and Robert Sundel⁷, ¹duPont Hospital for Children/Thomas Jefferson University, Wilmington, DE, ²Division of Immunology, Children's Hospital Boston, Boston, MA, ³Rheumatology, Children's Hospital Boston, Boston, MA, ⁴Paediatrics, University Children's Medical Institute, NUH, Singapore, Singapore, ⁵Departments of Anesthesia and Surgery, Boston Children’s Hospital, Boston, MA, ⁶SimulConsult, Chestnut Hill, MA, ⁷Immunology, Childrens Hospital, Boston, MA
Background/Purpose: This projects seeks to respond to the critical shortage of pediatric rheumatologists encapsulating the diagnostic information of the field in an advanced diagnostic decision…
Abstract Number: 2454 • 2015 ACR/ARHP Annual Meeting
Target and Targetoid Reactions at Bacillus Calmettee-Guérin Inoculation Site Revealed By Dermatoscopy Correlate with Systemic Involvements in Patients with Kawasaki Disease
Kuo Ho-Chang and Kawasaki Disease Center, Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Background/Purpose: For the past decades, the rash at the Bacillus Calmettee-Guérin (BCG) inoculation sites has been recognized as a useful diagnostic clue in Kawasaki disease…
Abstract Number: 2455 • 2015 ACR/ARHP Annual Meeting
Utilization and Education of Nurse Practitioners in Pediatric Rheumatology
Sandra Mintz¹, Karla B. Jones² and Andreas Reiff³, ¹4650 Sunset Boulevard, Mailstop 60, Children's Hospital of LA, Los Angeles, CA, ²Rheumatology, Nationwide Children's, Columbus, OH, ³Childrens Hosp LA MS60, Los Angeles, CA
Background/Purpose: Due to the shortage of subspecialty physicians there is an increasing need of adding mid-level practitioners to specialty practices (Solomon, Bitton, et.al., 2014). However…
Abstract Number: 2456 • 2015 ACR/ARHP Annual Meeting
Anti SRP+Ve Myositis in Childhood. Presentation and Physiotherapy Treatment of This Rare Childhood Myositis
Susan Maillard and Clarissa Pilkington, Paediatric Rheumatology, Great Ormond Street Hospital NHS Foundation Trust for Children, London, United Kingdom
Background/Purpose: Previously it was understood that all Myositis in childhood was Juvenile Dermatomyositis. More recently Myositis specific antibodies have been discovered and these appear to…
Abstract Number: 2457 • 2015 ACR/ARHP Annual Meeting
Physical Function and Psychological Well-Being in Teens with Juvenile Idiopathic Arthritis (JIA): Characterization and Exploration of Technology-Assisted Self-Management
Carrie Shotwell¹, Paula Melson², Jason Long³ and Tracy Ting⁴, ¹Occupational therapy and physical terapy, Cincinnati Children's Hospital Medical Center, CINCINNATI, OH, ²Rheumatology, Children's Hosp Medical Center, Cincinnati, OH, ³Orthopaedic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁴Rheumatology/MLC 4010, Cincinnati Children's Hosp, Cincinnati, OH
Background/Purpose: This study sought to assess the physical function and psychological well- being of teens with juvenile idiopathic arthritis (JIA) as well as to assess…
Abstract Number: 2458 • 2015 ACR/ARHP Annual Meeting
Psychostimulant-Induced Vasculopathy: A Retrospective Study in a Pediatric Rheumatology Clinic
Freda Singletary¹, Nirupma Sharma¹ and Rita Jerath², ¹Pediatrics, Georgia Regents University-Children's Hospital of Georgia, Augusta, GA, ²Dept of Pediatrics, Childrens Med Ctr Med Schl GA, Augusta, GA
Background/Purpose: Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood. The first line treatment is psychostimulant medications namely, methylphenidate, amphetamines, or their derivatives. …
Abstract Number: 2459 • 2015 ACR/ARHP Annual Meeting
Personal and Environmental Factors Associated with Leisure Participation Among Children and Adolescents with Juvenile Idiopathic Arthritis
Sabrina Cavallo¹, Annette Majnemer², Ciarán M. Duffy³ and Debbie Ehrmann Feldman⁴, ¹École de Santé Publique, Université de Montréal, Montreal, QC, Canada, ²School of Physical and Occupational therapy, McGill University, Montreal, QC, Canada, ³Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, ⁴School of Rehabilitation, Université de Montréal, Montreal, QC, Canada
Background/Purpose: To identify potential disease-related, personal and environmental factors associated with leisure in children and adolescents with juvenile idiopathic arthritis (JIA) according to the International…
Abstract Number: 2460 • 2015 ACR/ARHP Annual Meeting
B10 Cells May be Involved in Controlling Disease Activity in Polyarticular Juvenile Idiopathic Arthritis Patients
Qianzi Zhao¹ and Lawrence K. Jung², ¹Rheumatology, Children's National Medical Center, Washington, DC, ²Pediatric Rheumatology, Children's National Medical Center, Washington, DC
Background/Purpose: In addition to antibodies production, B cells have been shown to have down-regulatory function on immune response in both mouse and human. The down-regulatory…
Abstract Number: 2461 • 2015 ACR/ARHP Annual Meeting
Identification of Target Antigens for Anti-Endothelial Cell Antibodies in Patients with Pediatric Rheumatic Diseases Using Proteomics
Rie Karasawa¹, Mayumi Tamaki¹, Yanmin Chen², Kaiyu Jiang², Kazuo Yudoh¹ and James Jarvis², ¹Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan, ²Pediatrics, The University at Buffalo, Buffalo, NY
Background/Purpose: Juvenile dermatomyositis (JDM), the most common inflammatory myopathy of childhood, is a rare systemic autoimmune vasculopathy. Juvenile idiopathic arthritis (JIA), the most common pediatric…
Abstract Number: 2462 • 2015 ACR/ARHP Annual Meeting
Altered Expression of IL-10 Family Cytokines in Chronic Recurrent Multifocal Osteomyelitis Result in Enhanced Inflammasome Activation
Sigrun Hofmann¹, Angela Rösen-Wolff¹, Hermann Girschick², Henner Morbach³ and Christian Hedrich⁴, ¹Children's Hospital Dresden, Dresden, Germany, ²Children's Hospital, Berlin, Germany, ³Children's Hospital Würzburg, Würzburg, Germany, ⁴Pediatric Rheumatology and Immunology, Children's Hospital Dresden, Dresden, Germany
Background/Purpose: Chronic recurrent multifocal osteomyelitis (CRMO) is the most severe presentation of the autoinflammatory bone disorder chronic nonbacterial osteomyelitis (CNO). The pathophysiology of CNO remains…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].